Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wild

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 23, 2001
[Health policy decisions between rationing and rationalization--exemplified by erythropoietin in tumor anemia]C Wild, S Jonas
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 25, 2004
[Me-too pharmaceuticals -- marketing-strategies of drug producers and drug purchasers. Example: non-ionic contrast media]C Wild, S Puig
Vaccine|August 25, 2009
Decision support in vaccination policiesB Piso, C Wild
European Journal of Cancer Care|July 2, 2013
Measuring quality in cancer care: overview of initiatives in selected countriesC Wild, N Patera
Journal of Studies on Alcohol|March 29, 2001
Psychosocial determinants of perceived vulnerability to harm among adult drinkersT C Wild, J Cunningham
AIDS Research and Human Retroviruses|November 1, 1993
A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusionC Wild, T Greenwell, T Matthews
Environmental Health Perspectives|December 1, 1994
Linking genotoxic responses and reproductive success in ecotoxicologyS L Anderson, G C Wild
Academic Medicine : Journal of the Association of American Medical Colleges|September 1, 1991
Comparing examination scores and personality types of students from three classesG C Wild, B J Skipper
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
ESMO-MCBS v1.1: statistical and patient-relevant shortcomingsR Emprechtinger, N Grössmann, C Wild
Journal of Pharmaceutical Policy and Practice|April 29, 2021
EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?L Schmidt, O Sehic, C Wild
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 23, 2001
[Health policy decisions between rationing and rationalization--exemplified by erythropoietin in tumor anemia]C Wild, S Jonas
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 25, 2004
[Me-too pharmaceuticals -- marketing-strategies of drug producers and drug purchasers. Example: non-ionic contrast media]C Wild, S Puig
Vaccine|August 25, 2009
Decision support in vaccination policiesB Piso, C Wild
European Journal of Cancer Care|July 2, 2013
Measuring quality in cancer care: overview of initiatives in selected countriesC Wild, N Patera
Journal of Studies on Alcohol|March 29, 2001
Psychosocial determinants of perceived vulnerability to harm among adult drinkersT C Wild, J Cunningham
AIDS Research and Human Retroviruses|November 1, 1993
A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusionC Wild, T Greenwell, T Matthews
Environmental Health Perspectives|December 1, 1994
Linking genotoxic responses and reproductive success in ecotoxicologyS L Anderson, G C Wild
Academic Medicine : Journal of the Association of American Medical Colleges|September 1, 1991
Comparing examination scores and personality types of students from three classesG C Wild, B J Skipper
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
ESMO-MCBS v1.1: statistical and patient-relevant shortcomingsR Emprechtinger, N Grössmann, C Wild
Journal of Pharmaceutical Policy and Practice|April 29, 2021
EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?L Schmidt, O Sehic, C Wild
Pageof 19